WOLBACHIA AS A WEAPON AGAINST DENGUE
WOLBACHIA AS A WEAPON AGAINST DENGUE
Dear Mr. President: It is commonly said that to win a
war, we must first know our enemy. I think that that saying is very much
applicable in our war against dengue, and please allow me to explain what I mean
by that. To be clear, our enemy is not dengue itself, but the infected Aedes
mosquitos that are the carriers of the dengue virus. Not all mosquitos are
carriers, and not all Aedes mosquitos are carriers, only those that belong to
the Flavivirus genus are the carriers.
It goes without saying Sir, that to win the war
against the dengue virus, we must defeat not the disease itself, but the
carriers of the virus, namely the Aedes mosquitos. Going back to the subject of
knowing our enemy, we must know that mosquitos in general are arthropods belonging
to the class Insecta. Since we know already who or what our enemies are, the
next thing that we need to know is what weapons we need to fight them, so to
speak.
According to Microsoft Copilot, “Wolbachia is gram-negative
bacteria that infects a wide range of arthropods and some nematodes”. In other words,
Sir, Wolbachia is a bacterium that could be used as a weapon to fight against the
Aedes mosquito, simply it is an arthropod that is vulnerable to it. what can Wolbachia
do to the Aedes mosquito? First, it can live inside the cells of the host mosquito,
and the bacteria can be passed from one generation of the host to the next, through
the eggs. Secondly, it can do damage to the reproductive cycle of the host, such
as asexual reproduction, feminization and male killing. Thirdly, it can
function as a biocontrol agent that weakens the ability of mosquitos to
transmit viruses such as dengue and zika.
Copilot also says that the use of Wolbachia in the
Philippines is “still in the research and evaluation stage”, possibly within a
unit of the DOH. Copilot adds that “public sentiments towards this technology
is generally positive, but more studies and public engagement are needed to
ensure its safety and effectiveness. I can understand why the DOH is very
careful in releasing this bacterium for general use, because if mistakes are
made, we might cause some biohazard accidents that could go beyond the control
of the government.
In the meantime, Mr. President, the government should
also carefully weigh the pros and cons, because we could be losing the war already
as we speak. As of September, this year, the government reported about 208,000
cases of dengue, representing an increase of about 68% increase over the same
period last year. While waiting for a final approval Sir, perhaps you could
consider instructing the DOH to conduct a small pilot test in a controlled
environment? Perhaps the DOH could do it in a remote isolated island? IKE
SENERES/11-06-2024
Comments
Post a Comment